Edition:
United Kingdom

Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

172.00USD
22 Jun 2018
Change (% chg)

$2.19 (+1.29%)
Prev Close
$169.81
Open
$170.41
Day's High
$173.68
Day's Low
$170.18
Volume
536,073
Avg. Vol
363,555
52-wk High
$179.84
52-wk Low
$137.70

Summary

Name Age Since Current Position

Kevin Lobo

52 2014 Chairman of the Board, President, Chief Executive Officer

Glenn Boehnlein

56 2016 Chief Financial Officer, Vice President

David Floyd

57 2012 Group President - Orthopaedics

Graham Mclean

53 2017 President, Asia-Pacific

Viju Menon

2018 Group President - Global Quality and Business Operations

Timothy Scannell

53 2013 Group President - MedSurg and Neurotechnology

M. Fink

48 2016 Chief Human Resource Officer, Vice President

William Berry

52 2014 Principal Accounting Officer, Vice President, Corporate Controller

Bijoy Sagar

49 2014 Chief Information Officer, Vice President

Katherine Owen

47 2007 Vice President - Strategy and Investor Relations

Yin Becker

54 2016 Vice President - Communication and Public Affairs

Michael Hutchinson

47 2014 General Counsel

Mary Brainerd

64 2017 Independent Director

Srikant Datar

64 2009 Independent Director

Roch Doliveux

61 2010 Independent Director

Louise Francesconi

64 2006 Independent Director

Allan Golston

51 2011 Independent Director

Sherilyn McCoy

59 Independent Director

Andrew Silvernail

47 2013 Independent Director

Ronda Stryker

63 1984 Independent Director

Rajeev Suri

50 Independent Director

Biographies

Name Description

Kevin Lobo

Mr. Kevin A. Lobo is Chairman of the Board, President, Chief Executive Officer of the company. He was named Chairman of the Board in July 2014 and has served as President and Chief Executive Officer of the Company since 2012. He joined the Company as a Group President in April 2011. Prior thereto, he held leadership roles over eight years with Johnson & Johnson, including president of Ethicon Endo-Surgery. Mr. Lobo is also a director of Parker-Hannifin Corporation, a manufacturer of motion and control technologies and systems.

Glenn Boehnlein

Mr. Glenn S. Boehnlein is Chief Financial Officer, Vice President of the Company. Mr. Glenn joined Stryker in 2003 as the Vice President of Finance and IT for Stryker’s Endoscopy division and has taken on roles of increasing responsibility, including his current role as Group CFO of MSNT, which he assumed in 2011. He has a strong and established track record and will continue to uphold the financial standards and practices that enable Stryker’s growth. Glenn’s career began with achieving a CPA degree and rising to Partner at Arthur Andersen, where he worked with large private and public companies, including private offerings and M&A transaction consulting. He then spent three years with Success TV as the company’s CFO prior to joining Stryker. Glenn received his Bachelors and Masters in Accounting from Mississippi State University.

David Floyd

Mr. David K. Floyd is Group President - Orthopaedics of the company. He joins Stryker after 25 years in the medical technology and orthopaedics industry where he held a number of senior level leadership roles at DePuy, a division of Johnson and Johnson, Abbott Spine, AxioMed Spine, Centerpulse Orthopaedics and most recently as Chief Executive Officer for OrthoWorx.

Graham Mclean

Viju Menon

Timothy Scannell

Mr. Timothy J. Scannell is Group President - MedSurg and Neurotechnology of the company. Mr. Scannell was Group President, Spine and Endoscopy since November 2008. He had previously been President, Stryker Spine since 2005 and Vice President and General Manager, Stryker Spine since 2003. After joining the Company in 1990, Mr. Scannell is leadership roles at Stryker Endoscopy before being promoted to Vice President and General Manager, Stryker Biotech in 2001.

M. Fink

William Berry

Bijoy Sagar

Katherine Owen

Ms. Katherine Ann Owen is Vice President - Strategy and Investor Relations of the company. Prior to joining the Company, She served as a medical technology analyst at Merrill Lynch. Prior to that she held a similar position at Cowen & Co./SG Cowen and had been a corporate lending analyst at State Street Bank.

Yin Becker

Michael Hutchinson

Mary Brainerd

Ms. Mary K. Brainerd serves as an Independent Director of the company. Ms. Brainerd is Former President and Chief Executive Officer of HealthPartners, the largest, consumer-governed, nonprofit health care organization in the United States, which she led from 2002 to May 2017. Prior to joining HealthPartners in 1992, she held various executive roles with Blue Cross and Blue Shield of Minnesota from 1984 to 1992. She also serves as a director of Bremer Bank, a privately held regional financial services company. Ms. Brainerd’s extensive experience surrounding both health care delivery and insurance enable her to provide unique and invaluable insight to our Board discussions, particularly in light of the evolving landscape in the health care delivery and payer markets.

Srikant Datar

Dr. Srikant M. Datar, Ph.D., is an Independent Director of the Company. He is a Professor at the Graduate School of Business Administration of Harvard University since 1996. Faculty Chair of the Harvard Innovation Labs and Senior Associate Dean for University Affairs. From 1989 to 1996, he was Edmund W. Littlefield Professor at the Graduate School of Business, Stanford University. Dr. Datar is also a director of Novartis AG, a multinational pharmaceutical and consumer health products company, ICF International, Inc., a management, technology and policy consulting firm, and T-Mobile US, Inc., a provider of wireless voice, messaging and data services.

Roch Doliveux

Dr. Roch Doliveux, DVM, is an Independent Director of the Company, since June 21, 2010. He is a Chairman of the Board, Pierre Fabre SA, a global dermocosmetics and healthcare company. Chairman of GLG Institute, a community of senior executives for experience sharing and learning. Former Chief Executive Officer of UCB, a global biopharmaceutical company, for 10 years. He is also Chairman of the Board of the Vlerick Business School, a top-100 business school in the world based in Belgium and of the Caring Entrepreneurship Fund, a philanthropic organization to help entrepreneurs start their own business in healthcare.

Louise Francesconi

Ms. Louise L. Francesconi is an Independent Director of the Company, since July 26, 2006. She is Former Vice President of Raytheon Company and former President of Raytheon Missile Systems, which she led from 1996 to July 2008. She is Chairman of the Tucson Medical Center Healthcare Board of Trustees and a director of UNS Energy Corporation, a utility that delivers natural gas and electric service.

Allan Golston

Mr. Allan C. Golston is an Independent Director of the Company, since January 1, 2011. He President, United States Program for the Bill & Melinda Gates Foundation since 2006, and Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. Mr. Golston is also a director of Harley-Davidson, Inc., a manufacturer of motorcycles and accessories.

Sherilyn McCoy

Ms. Sherilyn S. McCoy is an Independent Director of the Company. She was Former Chief Executive Officer and Director of Avon Products, Inc., a personal care products company, which she led for almost 6 years until she retired on February 4, 2018. She remains an advisor to the Avon CEO and its board until March 31, 2018. Prior to joining Avon, Ms. McCoy had a 30-year career at Johnson & Johnson, where she led a variety of large medical device, pharmaceutical and consumer businesses and rose to the position of Vice Chair. She is also a director of AstraZeneca plc, a global, science-led biopharmaceutical company.

Andrew Silvernail

Mr. Andrew K. Silvernail is an Independent Director of the company. He is Chairman, President and Chief Executive Officer of IDEX Corporation, Chairman since 2012 and President and Chief Executive Officer since 2011, and Vice President, Group Executive from January 2009 to August 2011. Mr. Silvernail is also a trustee for the Manufacturers Alliance for Productivity and Innovation (MAPI).

Ronda Stryker

Ms. Ronda E. Stryker is an Independent Director of Stryker Corp., since 1984. She is also Vice Chair and a director of Greenleaf Trust, a Michigan chartered bank, Vice Chair of Spelman College, a trustee of Kalamazoo College and member of the Harvard Medical School Board of Fellows.

Rajeev Suri

Mr. Rajeev Suri is an Independent Director of the Company. He is President and Chief Executive Officer of Nokia, a leading global technology company, since April 2014. From 2009 to 2014, he was Chief Executive Officer of Nokia Solutions and Networks (previously Nokia Siemens Networks). Much of his nearly 30-year career has been spent in leadership roles at Nokia. He is also a United Nations Broadband Commissioner, a member of the steering committee of the Digital Communications Industry and a member of the stewardship Board of Health and Healthcare System Initiative at the World Economic Forum.